Petros Pharmaceuticals Inc. Common Stock
Exchange: NASDAQ
Symbol: PTPI
SEC CIK: 0001815903
Phone: 973-242-0005
1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK NY 10036
CEO:
|
Price when page updated: 1.26 Date: 2023-12-01
Company Website:
www.petrospharma.com
|
_Description: Petros Pharmaceuticals is committed to the goal of becoming a world-leading specialized men's health company by identifying, developing, acquiring, and commercializing innovative therapeutics for men's health issues including, but not limited to erectile dysfunction, endothelial dysfunction, psychosexual and psychosocial ailments, Peyronie's disease, hormone health and substance use disorders.
IPO YEAR:
|
Sector:
Health Care
|
Industry:
Biotechnology: Pharmaceutical Preparations
|
ADRTSO:
|
MarketCap:
2773347.00
|
Beta:
2.375561819418728
|
52 Week High:
5.2
|
52 Week Low:
1.19
|
52 Week Change:
-0.23931623931623924
|
Short Interest:
|
Short Date:
|
Shares Outstanding:
17988927
|
Dividend Rate:
0
|
Dividend Yield:
N/A
|
ExDividend Date:
|
Latest EPS:
|
Latest EPS Date:
N/A
|
Float:
0
|
return on Equity:
-
|
Consensus EPS:
|
Number Of Estimates:
|
EPS Surprise Dollar:
|
Eps Surprise Percent:
|
EBITDA:
-$13.01
|
ttmEPS:
0
|
Revenue:
$7.930M
|
Gross Profit:
|
Cash:
|
Debt:
|
Institution Percent:
3.80%
|
Revenue Percent:
|
Revenue Per Employee:
|
Insider Percent:
29.95%
|
Return on Assets:
-
|
Return on Capital:
|
Profit Margin:
-
|
Price to Sales:
1.01
|
Price To Book:
0.23
|
Short Ratio:
0.10
|
PE Ratio:
0
|
Employees:
27
|
1Y Guesstimate
0.320:0.0:2
|
|
|
|
|
|
|
|
|
__The following are links to various summary and news pages for
__Petros Pharmaceuticals Inc. Common Stock [ PTPI ].
__Note: Some Links might not have information for the company.
|
|
